Urovant Sciences & Sunovion Pharmaceuticals Launch Promotion of GEMTESA For Overactive Bladder Patients
In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read moreIn full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read moreThe following is a press release summitted to SOURCE media through its business wire service *** MARLBOROUGH- Sunovion Pharmaceuticals Inc. announced
Read moreThe following is a press release submitted to SOURCE media through its business wire service *** MARLBOROUGH – Sunovion Pharmaceuticals
Read moreThe following is a press release from Marlborough-based Sunovion Pharmaceuticals submitted to SOURCE media through its business wire. *** MARLBOROUGH
Read moreMARLBOROUGH – Urovant Sciences yesterday, June 18, announced it has entered into an exclusive 3-year distribution agreement with Sunovion Pharmaceuticals
Read more